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MHC Class I Ubiquitination
by a Viral PHD/LAP Finger Protein
(Ishido et al., 2000a; Coscoy and Ganem, 2000; Steven-
son et al., 2000). KK5 also reduces the levels of intercel-
lular adhesion molecule-1 (ICAM-1) and B7-2 (Ishido et
Jessica M. Boname and Philip G. Stevenson1
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University of Cambridge al., 2000b). Although CD8 T cells do contribute to the
control of acute MHV-68 infection (Ehtisham et al., 1993;Tennis Court Road
Cambridge CB2 1QP Weck et al., 1996; Stevenson et al., 1999a), CD8 T
cell evasion by this virus clearly has consequences forUnited Kingdom
pathogenesis in vivo. Thus, CD4 T cell-deficient I-Ab/
mice control MHV-68 replication acutely but, unlike im-
munocompetent congenics, subsequently succumb toSummary
the effects of chronic lytic infection (Cardin et al., 1996).
This is not due to a loss of virus-specific CD8 T cellsThe murine -herpesvirus-68 K3 (MK3) is a PHD/LAP
finger protein that downregulates major histocompati- (Stevenson et al., 1998) and is furthermore not prevented
by even very high levels of CD8 T cell immunity (Belzbility complex (MHC) class I expression. In transfected
cell lines, MK3 was expressed in the endoplasmic re- et al., 2000) to immunodominant lytic phase epitopes
(Stevenson et al., 1999b). The implication is that at leastticulum (ER) membrane, where it bound the cyto-
plasmic tail of newly synthesized H-2Db glycoproteins outside of an acute inflammatory setting, MHV-68 effec-
tively evades CD8 T cell immunity during lytic cycleand targeted them for degradation. Proteasome inhibi-
tors blocked the degradation and led to an accumula- replication.
KK3 and KK5 promote the endocytosis of their targettion of ubiquitinated H-2Db. Because this retained its
native conformation, ubiquitination preceded any de- glycoproteins from the cell surface (Ishido et al., 2000a;
Coscoy and Ganem, 2000), whereas MK3 expressionnaturation or dislocation to the cytosol. The PHD/LAP
finger of MK3 was not required for H-2Db binding but results in a loss of 28.14.8-reactive H-2Db before it leaves
the ER (Stevenson et al., 2000). Despite this difference,was essential for its ubiquitination and degradation.
Thus, -herpesviruses have adapted the cellular PHD/ the homology and common functions of MK3, KK3, and
KK5 suggest that they act by similar mechanisms. AllLAP motif to immune evasion, apparently for the catal-
ysis of MHC class I ubiquitination. of the K3 homologs share a highly conserved N-terminal
PHD/LAP zinc binding finger (Nicholas et al., 1997). This
motif (C4HC3) is also found in a range of eukaryotic pro-Introduction
teins, suggesting that the viral version exploits estab-
lished cellular pathways. PHD/LAP fingers have beenHerpesviruses have evolved to persist in immunocom-
petent hosts. One prerequisite for successful persis- implicated in transcriptional regulation (Aasland et al.,
1995), DNA binding (Saha et al., 1995), and protein-tence is immune evasion (Tortorella et al., 2000), and
CD8 T cell evasion by an inhibition of major histocom- protein interactions (Lyngso et al., 2000). Proteins with
RING-HC (C3HC4) or RING-H2 (C3H2C3) zinc fingers havepatibility complex (MHC) class I-restricted antigen pre-
sentation is a common feature of -, - and -herpesvi- similarly diverse functions, but here a common theme
is E3 ubiquitin-protein ligase activity (Lorick et al., 1999;rus biology. Understanding the mechanisms involved
can reveal not only how herpesviruses cause disease, Joazeiro et al., 1999). Thus, a range of RING finger pro-
teins directs specific substrates to the proteasome forbut also how fundamental pathways of cell biology oper-
ate, as viruses often subvert these to their own ends. destruction. Herpesviruses have exploited RING fingers
for their own ends; for example, the RING motif of theViral degradation of MHC class I glycoproteins is a case
in point. The murine cytomegalovirus m06 protein em- herpes simplex virus ICP0 promotes efficient viral repli-
cation through proteasomal degradation of host nuclearploys a cellular sorting signal to direct MHC class I
complexes to lysosomes (Reusch et al., 1999), whereas proteins (Everett, 1999). The K3 gene family of 2-her-
pesviruses presumably represents exploitation of cellu-the US2 (Wiertz et al., 1996a) and US11 (Wiertz et al.,
1996b) proteins of human cytomegalovirus exploit a nor- lar PHD/LAP finger function. Here we have analyzed the
mechanism by which MK3 downregulates H-2Db expres-mal quality control pathway (Hughes et al., 1997), dislo-
cating human lymphocyte antigen (HLA) class I glyco- sion, in particular the role played by its PHD/LAP motif.
proteins from the endoplasmic reticulum (ER) to the
cytosol for destruction. US2 also degrades HLA class II Results
components, probably by a similar route (Tomazin et
al., 1999). Localization of MK3 Expression
Three related 2-herpesvirus genes, the Kaposi’s sar- The MK3 ORF (Virgin et al., 1997) encodes an N-terminal
coma-associated herpesvirus K3 (KK3) and K5 (KK5) PHD/LAP finger, followed by two closely spaced hy-
and the murine -herpesvirus-68 (MHV-68) K3 (MK3) all drophobic segments (Figure 1A). This arrangement is
downregulate MHC class I glycoprotein expression in conserved in KK3 and KK5, which differ from MK3 mainly
vitro and are thus implicated in CD8 T cell evasion in their C-terminal domains (Nicholas et al., 1997). MEF-1
cells transfected with flag-tagged MK3 showed perinu-
clear anti-flag staining that colocalized with the ER pro-1Correspondence: pgs27@mole.bio.cam.ac.uk
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Figure 1. Characterization of the MK3 Protein
(A) Amino acid sequence of the MK3 ORF. The PHD/LAP motif is underlined in bold, with the putative zinc binding residues in bold type. The
dashed underlined region lies outside the canonical PHD/LAP motif but shows homology to the corresponding region of the RING finger
protein rbx-1, an E3 ubiquitin-protein ligase component. The hydrophobic, proposed transmembrane regions are double underlined. (1) is the
site of translation initiation in MK3-DEL (N-terminal truncation); (2) shows the cysteine residues mutated to glycines in MK3-MUT; and (3) shows
the site of translation termination in MK3-CT (C-terminal truncation).
(B) Localization of MK3 expression. MEF-1 cells transfected with flag-MK3 in pcDNA3 (Invitrogen) were fixed, permeabilized, and stained for
flag epitope (a, d, g), and calreticulin (b), calnexin (e), or LAMP-1 (h), as indicated. (a) and (b) are overlaid in (c), and (d) and (e) are overlaid
in (f), with colocalization (yellow) of flag-MK3 and calreticulin or calnexin respectively. (g) and (h) are overlaid in (i), with no colocalization of
LAMP-1 and flag-MK3.
(C) Membrane association of MK3. Metabolically labeled RMA or RMA-flag-MK3 cells were homogenized with or without 1% Triton X-100
and then either unfractionated (U) or separated by centrifugation (100,000  g, 60 min) into pellet (P) and supernatant (S) fractions. MK3 was
recovered by immune precipitation with anti-flag mAb. The positions of molecular weight markers are indicated. MK3 has a predicted molecular
weight of 24 kDa (arrow).
(D) Orientation of MK3 N and C termini. RMA (control: pink histograms), RMA-MK3-flag (C-terminal flag tag: green), and RMA-flag-MK3 cells
(N-terminal flag tag: black) were untreated, subjected to limited plasma membrane permeabilization with streptolysin-O, or fully permeabilized
with Triton X-100 as indicated. Cells were then stained with anti-flag mAb plus goat anti-mouse IgG-FITC to determine whether the flag-
tagged end of MK3 was accessible to antibody or rabbit anti-calreticulin plus swine anti-rabbit IgG-FITC to determine whether antibody could
reach the ER lumen.
teins calreticulin and calnexin but not with the lysoso- the flag epitope in RMA-flag-MK3 and RMA-MK3-flag
mal marker lysosome-associated membrane protein-1 cells, but not in RMA cells. All Triton X-100-treated cells
(LAMP-1) (Figure 1B). Thus, MK3 was expressed pre- stained with anti-calreticulin, indicating disruption of both
dominantly in the ER. Because the colocalization was the cell and ER membranes. Selective permeabilization
not perfect, MK3 may also be expressed in other sites of the cell membrane with streptolysin-O also revealed
or in distinct subcompartments of the ER. However, the flag epitope in both RMA-flag-MK3 and RMA-MK3-
there was no sign of MK3 expression in lysosomes or flag cells. A mild permeabilization protocol—approx-
at the cell membrane. imately 30% of streptolysin-O-treated cells still ex-
RMA cells stably expressing flag-MK3 were then la- cluded Trypan blue—was used to ensure that the ER
beled with 35S-methionine/35S-cysteine, homogenized, membrane was not disrupted, and this was confirmed
and separated by ultracentrifugation into membrane by the absence of anti-calreticulin staining. Thus, not
(pellet) and soluble (supernatant) fractions. Immunopre- all of the RMA-flag-MK3 and RMA-MK3-flag cells
cipitation with anti-flag mAb (Figure 1C) recovered la- stained with anti-flag after streptolysin-O treatment be-
beled MK3 only from the membrane pellet. When cellular
cause not all were permeabilized. The fact that a propor-
membranes were solubilized with Triton X-100 before
tion of each was stained indicated that neither anultracentrifugation, MK3 was recovered only from the
N-terminal nor a C-terminal flag tag on MK3 was con-supernatant. Thus, MK3 was membrane associated and,
tained within the ER lumen. It remains possible thatin view of its localization by immune fluorescence (Figure
MK3 binds to a protein on the cytosolic face of the ER1B), most likely expressed in the ER membrane.
membrane. However, the simplest interpretation is thatNext, the N and C termini of MK3 were identified by
at least in the presence of epitope tags, MK3 has bothflow cytometric analysis of RMA cells expressing either
N-terminal and C-terminal cytosolic domains and thatN-terminal or C-terminal flag-tagged forms of the protein
each hydrophobic domain traverses the ER membrane,(Figure 1D). There was no staining of intact cells, consis-
leaving only the intervening 11 amino acids in the ERtent with the intracellular localization of MK3 by immune
fluorescence. Permeabilization with Triton X-100 revealed lumen.
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Figure 2. H-2Db Assembly and Degradation
in RMA-Flag-MK3 Cells
(A) RMA and RMA-flag-MK3 cells were pulse
labeled for 15 min [P] and chased for 45 min
[C], followed by immunoprecipitation of H-2Db
with either 28.14.8 or B22.249 mAbs and di-
gestion () or not () with endo H. The posi-
tions of molecular weight markers are shown.
(B) In a separate experiment, RMA/S cells,
which are deficient in peptide transport into
the ER, were labeled and H-2Db immunopre-
cipitated as in panel (A).
(C) RMA (filled histograms) and RMA-MK3
cells (open histograms) were stained for
CD54 or CD71 as indicated. No effect of MK3
on these glycoproteins was apparent. Cell
surface H-2Db downregulation on RMA-flag-
MK3 cells is illustrated in Figure 4A.
MK3-Mediated H-2Db Degradation The proteasome-dependent degradation of HLA class
I heavy chain effected by US2 or US11 proceeds viaIs Not Due to Misfolding
Previous work had established that MK3 downregulates a deglycosylated intermediate, due to digestion by a
cytosolic N glycanase (Wiertz et al., 1996a, 1996b). InH-2Db and H-2Kb expression in fibroblasts and leads
to a rapid loss of 28.14.8-reactive H-2Db in RMA cells contrast, the H-2Db rescued from MK3-mediated degra-
dation by proteasome inhibition was of normal size (Fig-(Stevenson et al., 2000). MK3 also downregulates H-2Dd,
H-2Kd, H-2Kk, and H-2Lq and is functional in B lympho- ure 3A). Endo F digestion confirmed that it retained
N-linked glycans (Figure 3B). Thus, there was no evi-cyte and macrophage cell lines (P.G.S., unpublished
data). MK3 with an N-terminal flag tag (flag-MK3) was dence that H-2Db was dislocated to the cytosol by MK3
when the proteasome was inhibited. A more prolongedfully effective at MHC class I downregulation and degra-
dation (Figure 2A), and this construct was used in all chase (Figure 3C) demonstrated that H-2Db rescued
from MK3-mediated degradation by proteasome inhibi-further studies. Because the 28.14.8 epitope is indepen-
dent of peptide and 2-microglobulin (2m) binding tion could mature to an endo H-resistant form, indicating
progress to the trans-Golgi and thus implying that it(Townsend et al., 1990), the H-2Db detected after pulse
labeling was possibly misfolded and consequently de- retained a proper, membrane-bound conformation.
To identify any H-2Db rescued from degradation bygraded by normal cellular pathways. Thus, we compared
28.14.8 with B22.249, a mAb that recognizes only H-2Db proteasome inhibition that was denatured and thus un-
reactive with 28.14.8, we used anti-myc mAb to recoverproperly assembled with peptide and 2m (Townsend
et al., 1990) (Figure 2A). The peptide-dependent B22.249 H-2Db from L929 cells (H-2k) expressing flag-MK3 and
full-length myc-tagged H-2Db (Figure 3D). Without lacta-signal was an equivalent proportion of the 28.14.8 signal
in both RMA (57%) and RMA-flag-MK3 cells (67%). In cystin, the loss of 28.14.8-reactive H-2Db was mirrored
by a loss of anti-myc-reactive H-2Db. This confirmedcontrast, B22.249 detected 5% of the 28.14.8 signal
in TAP-deficient RMA/S cells (Figure 2B). This implied H-2Db degradation rather than denaturation. With lacta-
cystin present, there was at least as good recovery ofthat H-2Db assembly was normal in RMA-flag-MK3 cells.
It was further apparent that the misfolded H-2Db in intact H-2Db with 28.14.8 as with anti-myc, indicating
that the majority of rescued heavy chain retained aRMA/S cells, which was retained in the ER and conse-
quently remained endo H sensitive, was more stable folded 3 domain. One smaller band was apparent spe-
cifically in the lactacystin-treated L929 cells that couldthan either B22.249-reactive or 28.14.8-reactive H-2Db
in RMA-flag-MK3 cells (Figure 2B). Thus, MK3 actively conceivably represent an H-2Db degradation intermediate.
However, this was a minor species. Overall, the data fromtargeted the heavy chain of properly folded complexes
for degradation. No effect of MK3 was observed on Figure 2 and Figure 3 argued for a mechanism of MK3
action distinct from that of the human cytomegalovirusthe expression of CD54 (ICAM-1) or CD71 (transferrin
receptor) (Figure 2C). In other experiments (data not US2 and US11, with little or no evidence for H-2Db disloca-
tion to the cytosol as a primary event. Instead, MK3 wasshown), we further observed no effect of MK3 on CD80
(B7-1) or CD58 (LFA-3). somehow targeting native H-2Db to the proteasome.
PHD/LAP MK3 Mutants Bind H-2Db but Do NotH-2Db Degradation Is Proteasome Dependent
The loss of labeled H-2Db in RMA-flag-MK3 cells was Cause Its Degradation
The absolute conservation of the PHD/LAP motif withinlargely prevented by the proteasome inhibitor MG-132
(Figure 3A). Lactacystin, a more specific proteasome the K3 gene family implies that it plays a crucial role
in protein function. This was established for MK3 byinhibitor, was also effective (Figure 3B), whereas inhib-
iting lysosomal degradation with chloroquine (Figure 3A) deleting the N-terminal part of the PHD/LAP motif or by
disrupting two of the canonical cysteine residues. Eitheror NH4Cl (data not shown) had no effect. A proteasomal
pathway of degradation was consistent with its rapid mutation completely abrogated the downregulation of
H-2Db (Figure 4A). The same was true of H-2Kb, H-2Dd,kinetics and the fact that H-2Db was degraded before it
left the ER to acquire endo H resistance (Figure 2A) and H-2Kd (data not shown). Pulse-chase analysis estab-
lished that H-2Db was not rapidly degraded by the MK3(Stevenson et al., 2000).
Immunity
630
Figure 3. Effect of Proteasome Inhibition on
MK3-Mediated H-2Db Degradation
(A) RMA and RMA-flag-MK3 cells were meta-
bolically labeled for 15 min [P] and chased
for 45 min [C] prior to immune precipitation
with 28.14.8 mAb. Labeling and chasing were
carried out with 50 M MG-132 to inhibit pro-
teasomes, 1 M chloroquine to inhibit lyso-
some function, or without inhibitors as indi-
cated.
(B) Labeling and immune precipitation were
performed as in (A), except that 20 M lacta-
cystin was used () as a proteasome inhibi-
tor, and the recovered products were further
digested () or not () with endo F.
(C) RMA and RMA-flag-MK3 cells were pulse
labeled for 15 min and chased for 90 min in
the presence of 20 M lactacystin to allow
maturation of rescued H-2Db to endo H re-
sistance before immunoprecipitation with
28.14.8 and endo H digestion.
(D) L929 cells expressing full-length, myc-
tagged H-2Db, plus either flag-MK3 or an inactive double-cysteine mutant (flag-MK3-MUT; see Figure 4) were treated or not with 100 M
lactacystin and pulse labeled for 15 min followed by a 90 min chase. H-2Db was recovered by immunoprecipitation with either 28.14.8 or anti-
myc mAb. Anti-myc mAb recovered one lower molecular weight band after the chase that was not apparent with 28.14.8 (arrow).
mutants (Figure 4B) and that the MK3 mutants were not vented MK3-mediated downregulation (Figure 6C).
When six amino acid residues (KRRRNT) of the H-2Db tailthemselves unstable (Figure 4C).
We hypothesized that MK3 must associate with H-2Db were included before the terminal epitope tag (H-2Db-S-
myc), there was some downregulation in cells express-so as to degrade it. To establish this, RMA-flag-MK3
cells were treated with lactacystin during metabolic la- ing MK3, compared with those expressing MK3-MUT,
but this was much less marked than with full-length H-2Dbbeling to prevent H-2Db degradation and lysed in digito-
nin buffer prior to immune precipitation of MK3 with (H-2Db-L-myc). The H-2Db-VS-myc truncation was found
to abrogate both H-2Db degradation and MK3 bind-anti-flag mAb (Figure 5A). Solubilization of the recovered
proteins in buffer with Triton X-100 and reprecipitation ing—no MHC class I heavy chain was recovered from
a complex with MK3 (Figures 6D and 6E). MK3-mediatedwith 28.14.8 then recovered H-2Db from the anti-flag
precipitates (Figure 5B). MK3 could also be recovered by degradation of H-2Db-S-myc was much less than that
of H-2Db-L-myc (Figure 6D), consistent with the limitedprimary precipitation with anti-H-2Db and reprecipitation
with anti-flag (data not shown). Thus, MK3 associated downregulation of surface H-2Db observed by flow cy-
tometry; however, there was no defect in MK3 bindingwith H-2Db, although a possible requirement for other
proteins in the complex was not excluded. H-2Db could (Figure 6E). Indeed, the recovery of H-2Db-L-myc from
MK3 was poor in comparison with H-2Db-S-myc (Figurealso be recovered from anti-flag precipitates of the PHD/
LAP MK3 mutants (Figure 5B), establishing that although 6E), perhaps because of incomplete proteasome inhibi-
tion or an incapacity of MK3 to process and thus tothe PHD/LAP finger was essential for H-2Db degradation,
it was not required for MK3 binding. Interestingly, higher release H-2Db-S-myc.
molecular weight bands, consistent with covalent modi-
fications of H-2Db, were reprecipitated from a complex
MK3 Induces the Accumulation of Ubiquitinated
with MK3, but not from complexes with the PHD/LAP
H-2Db When the Proteasome Is Inhibited
MK3 mutants (Figure 5B). This raised the possibility that
The size distribution of the higher molecular weight
these higher molecular weight forms were H-2Db degra-
forms of H-2Db associated with MK3 (Figure 5B) sug-
dation intermediates.
gested that they were ubiquitinated heavy chains. This
was further supported by immunoprecipitating H-2Db
from MG-132-treated RMA-flag-MK3 and RMA-flag-Binding Involves the C-Terminal Domain of MK3
and the Cytoplasmic Tail of H-2Db MK3-MUT cells with 28.14.8 or B22.249, followed by
reprecipitating with an anti-ubiquitin mAb, FK2 (FiguresMK3 with a C-terminal truncation (MK3-CT) did not de-
grade H-2Db (Figure 6A), despite an intact PHD/LAP 7A and 7B). The anti-ubiquitin mAb specifically recov-
ered higher molecular weight H-2Db bands from bothfinger. Reprecipitation of H-2Db from anti-flag precipi-
tates provided a possible reason, in that MK3-CT 28.14.8 and B22.249 precipitates. The lower 46 kDa band
seen also in the control reprecipitates probably repre-showed no evidence of H-2Db binding (Figure 6B). We
presumed that the cytosolic MK3 C-terminal domain sents residual unmodified H-2Db from the primary pre-
cipitates, visible here because of the longer exposurewas binding the cytosolic tail of H-2Db. Thus, we next
tested C-terminal truncations of H-2Db to identify a more necessary to see ubiquitinated products. The presence
of ubiquitin in the higher molecular weight bands wasprecise region of interaction.
Completely removing the cytosolic tail of H-2Db and confirmed by reprecipitation of the primary H-2Db/
28.14.8 complexes with another murine anti-ubiquitinreplacing it with a myc epitope tag (H-2Db-VS-myc) pre-
Viral MHC Class I Ubiquitination
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Figure 5. MK3 Association with the H-2Db Heavy Chain
(A) RMA, RMA-flag-MK3 (MK3), RMA-flag-MK3-MUT (MUT), and
RMA-flag-MK3-DEL (DEL) cells were metabolically labeled in the
presence of 20 M lactacystin. All cells were lysed in 1% digitonin
buffer, and flag-tagged MK3 derivatives (arrows) were recovered by
immune precipitation. The bands seen in the RMA cell lane represent
cellular proteins bound nonspecifically by the anti-flag mAb under
digitonin lysis conditions. These showed no evidence of association
with H-2Db.
(B) The proteins recovered with anti-flag were then solubilized in
1% Triton X-100 buffer and reprecipitated with 28.14.8. The MK3
band was not seen after reprecipitation because the association
between MK3 and H-2Db is not maintained in 1% Triton X-100 buffer
(data not shown). The primary precipitation products were exposed
for 1 week and the secondary precipitation products for 1 month.
H-2Db apparent in Figures 5B and 5E were also promi-
nent, but again, very high molecular weight productsFigure 4. Effect of MK3 PHD/LAP Finger Disruption on H-2Db Down-
regulation corresponding to polyubiquitinated H-2Db were not ob-
(A) Cell surface H-2Db expression was quantitated by flow cytometry served.
of the following: RMA cells; RMA-flag-MK3 cells; RMA-flag-MK3- The relative lack of H-2Db-S-myc degradation despite
MUT cells, in which two cysteines of the MK3 PHD/LAP motif were its association with MK3 presumably reflected the lack
changed to glycines; or RMA-flag-MK3-DEL cells, in which most of
of an efficiently utilized ubiquitination site. The cyto-the PHD/LAP motif was deleted (Figure 1A). Cells were stained
plasmic tail of H-2Db was confirmed as the target forwith 28.14.8 plus goat anti-mouse IgG-FITC (filled histograms) or
MK3-mediated degradation by mutating its three lysinesecondary antibody only (open histograms).
(B) RMA-flag-MK3-MUT and RMA-flag-MK3-DEL cells were as- residues (amino acids 301, 309, and 330 of the mature
sayed for H-2Db degradation by 15 min pulse [P] labeling and 45 protein) to arginines (H-2Db-ARG), this time without a
min chase [C] in the absence of proteasome inhibitors, followed by C-terminal myc epitope tag. A comparison of cell surface
immune precipitation with 28.14.8. The recovered products were H-2Db expression showed that downregulation wasdigested () or not ()with endo H. Figure 2A illustrates a compara-
much less in the absence of cytoplasmic lysine residuesble pulse/chase labeling of H-2Db in RMA and RMA-flag-MK3 cells.
(Figure 7C). This was mirrored by the relative lack of(C) After 15 min of pulse [P] labeling and 45 min chase [C] of RMA-
flag-MK3 (MK3), RMA-flag-MK3-MUT (MUT), RMA-flag-MK3-DEL H-2Db-ARG degradation observed after pulse-chase
(DEL), and RMA cells without proteasome inhibitors, flag-tagged metabolic labeling and immune precipitation with
MK3 and MK3 mutants were recovered by immune precipitation 28.14.8 (Figure 7D). The protection of H-2Db-ARG
with anti-flag-agarose. The positions of molecular weight markers against degradation was not due to a lack of MK3 bind-
are shown.
ing (Figure 7E). Surprisingly, however, neither did the
lack of H-2Db cytoplasmic lysines prevent MK3-depen-
mAb (Covance, Horsham, UK) and with a rabbit anti- dent ubiquitination. The H-2Db-ARG recovered from
ubiquitin polyclonal serum (Affiniti, Exeter, UK), each MK3 immune precipitates included higher molecular
of which gave similar results to FK2 (data not shown). weight forms suggestive of ubiquitination (Figure 7E),
Notably, no higher molecular weight H-2Db bands were and this identity was confirmed by reprecipitation of
observed with the MK3 zinc finger mutant (Figures 7A primary 28.14.8 precipitates with anti-ubiquitin mAb
and 7B). Thus, the ubiquitination of H-2Db, like its degra- (Figure 7F). Thus, although efficient MK3-mediated
dation but unlike binding, required an intact MK3 PHD/ H-2Db downregulation depended on cytoplasmic tail
LAP finger. The requirement of 28.14.8 for a folded 3 ubiquitination, there was also the potential to ubiquiti-
domain and of B22.249 for fully assembled H-2Db with nate other residues, perhaps through partial dislocation
peptide implied that H-2Db was ubiquitinated while in to the cytosol.
its native conformation in the ER membrane, that is that
ubiquitination was the primary event in MK3-mediated Discussion
H-2Db degradation. In Figures 7A and 7B, monoubiquiti-
nated H-2Db was the dominant species. In other experi- MK3 was found to cause rapid, proteasome-dependent
H-2Db degradation. The mechanism was distinct fromments, the diubiquitinated H-2Db and triubiquitinated
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that employed by the US2 and US11 proteins of human
cytomegalovirus, since ubiquitination of MHC class I
heavy chain rather than dislocation to the cytosol was
the primary event. With proteasome inhibition, the bulk
of newly synthesized H-2Db matured normally. MK3
bound to the cytoplasmic tail of the H-2Db heavy chain.
Lysine residues in this tail were not involved in MK3
binding and were not the only possible target for MK3-
mediated ubiquitination but were nevertheless required
for efficient H-2Db degradation. The PHD/LAP finger of
MK3 was crucial to both ubiquitin transfer and H-2Db
degradation; when it was disrupted, neither process oc-
curred, even though the binding between MK3 and
H-2Db was maintained. Thus, MK3 represents immune
evasion achieved through the adaptation of a cellular
PHD/LAP motif to MHC class I heavy chain ubiquiti-
nation.
The cytosolic C-terminal domain of MK3 was essential
for its association with newly synthesized H-2Db heavy
chains in the ER membrane and consequently for H-2Db
degradation. Truncating the corresponding cytoplasmic
tail of H-2Db identified the six membrane-proximal amino
acids as a target for MK3. Although the participation of
additional cellular proteins was not excluded, it seems
likely that it is the C-terminal domain of MK3 that binds
this cluster of positively charged residues. Because a
similar motif is present not only in different MHC class
I alleles, but also in a variety of other membrane proteins,
MK3 has the potential to alter cell surface phenotypes
substantially. There may also be other determinants of
MK3 substrate binding. The transmembrane region of
HLA-A2 has been implicated in its interaction with KK5
(Ishido et al., 2000a), although interestingly, the region
identified includes 11 cytoplasmic residues, suggesting
that the membrane-proximal cytoplasmic tail might be
important here, too.
The dislocation of misfolded ER proteins to the cyto-
sol through the Sec 61 translocon is a highly conserved
mechanism of eukaryotic quality control (Bonifacino and
Weissman, 1998; Brodsky and McCracken, 1999; Kor-
nitzer and Ciechanover, 2000). Ubiquitination, disloca-
tion, and digestion by the proteasome are tightly linked
components of this process (Biederer et al., 1997; Mayer
et al., 1998; de Virgilio et al., 1998; Plemper and Wolf,Figure 6. Identification of Elements Essential to the Interaction be-
tween MK3 and H-2Db 1999). In general, soluble substrates enter the degrada-
tion pathway through dislocation. A RING-H2 finger E3(A) RMA, RMA-flag-MK3 (MK3), and RMA-flag-MK3-CT (CT) cells
were assayed for H-2Db degradation by 15 min pulse [P] labeling ubiquitin-protein ligase associated with Sec 61, Hrd1p
and 90 min chase [C] without proteasome inhibitors, followed by in yeast, then catalyses their ubiquitination (Bordallo et
immunoprecipitation with 28.14.8. MK3-CT lacks the terminal 39 al., 1998; Friedlander et al., 2000; Bays et al., 2001).
amino acid residues of intact MK3 (Figure 1A).
Membrane proteins can enter the degradation pathway(B) The same cell lines were metabolically labeled in the presence
through either dislocation or ubiquitination (Yang et al.,of 20 M lactacystin. MK3 derivatives (arrows) were recovered by
anti-flag immunoprecipitation in 1% digitonin buffer, followed by 1998). Human cytomegalovirus uses MHC class I dislo-
reprecipitation of bound H-2Db with 28.14.8 in 1% Triton X-100 cation to initiate its degradation (Shamu et al., 1999);
buffer. There was no evidence of an association between MK3-CT our data indicate that MHV-68 uses ubiquitination to
and H-2Db. achieve the same end. Ubiquitination has also been ex-
(C) H-2Db mutants with different cytoplasmic tails, but all with a
C-terminal myc epitope tag, were stably coexpressed with either
flag-MK3 or flag-MK3-MUT in L929 cells. H-2Db-L-myc (Db-L) is the
full-length protein. H-2Db-VS-myc (Db-VS) lacks the entire cyto-
[C] for 45 min without proteasome inhibitors. H-2Db was recoveredplasmic tail, and H-2Db-S-myc (Db-S) includes six amino acid resi-
dues of the tail (KRRRNT) before the epitope tag. L929 cells express- by immunoprecipitation with 28.14.8.
(E) L929-flag-MK3 cells expressing each form of H-2Db were meta-ing flag-MK3 (open histograms) or flag-MK3-MUT (filled histograms),
and either full-length or truncated H-2Db, as indicated, were ana- bolically labeled in the presence of 50 M MG-132. MK3 was then
recovered by immunoprecipitation with anti-flag mAb (arrow) andlyzed for cell surface H-2Db expression by flow cytometry.
(D) The same cell lines were pulse labeled [P] for 15 min and chased any associated H-2Db recovered by reprecipitation with 28.14.8.
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ploited by HIV, with an h- TrCp recognition sequence in
Vpu promoting the proteasome-dependent degradation
of associated CD4 (Schubert et al., 1998; Margottin et al.,
1998). The 2-herpesviruses, with their greater coding
capacity, have gained control of ubiquitination through
piracy of the cellular PHD/LAP finger.
There is clearly flexibility in ER quality control. Degra-
dation of the T cell receptor  chain is ubiquitin depen-
dent, but occurs even in the absence of lysine residues,
perhaps through partial dislocation revealing the N ter-
minus for conjugation (Yu and Kopito, 1999). The ubiqui-
tination of normal T cell receptor  chain, which lacks
cytoplasmic lysine residues, also involves partial dislo-
cation (Yang et al., 1998). The interaction between MK3
and H-2Db could apparently result in partial dislocation,
as H-2Db ubiquitination occurred even in the absence
of cytoplasmic lysines. However, this was much less
efficient than cytoplasmic tail ubiquitination in driving
H-2Db degradation, as little downregulation of cell-sur-
face H-2Db-ARG expression by MK3 was observed (Fig-
ure 7C). The retrovirus-transduced cell populations used
are polyclonal, and ubiquitination independent of cyto-
plasmic lysine residues perhaps occurred only with high
levels of MK3 expression.
The proteasome requires tetraubiquitination to pro-
vide sufficient avidity for binding model soluble sub-
strates (Thrower et al., 2000). Given the role of the pro-
teasome in MK3-mediated degradation, it was thus
surprising that no more than triubiquitination of H-2Db
was observed (Figure 7). This was true even when using
the conformation-independent myc epitope tag to im-
munoprecipitate MHC class I (data not shown). It is pos-
sible that polyubiquitinated H-2Db was not observed
because of extreme instability. Alternatively, the relative
immobility of membrane-bound substrates may allow
less heavily ubiquitinated forms to be recognized by
membrane-associated proteasomes. The monoubiquiti-
Figure 7. H-2Db Heavy Chain Ubiquitination
(A and B) H-2Db was immunoprecipitated from metabolically labeled,
MG-132-treated RMA-MK3 and RMA-MK3-MUT cells using 28.14.8
(A) or B22.249 (B) and then dissociated by heating (37	C for 60 min)
in the presence of 1% sodium dodecyl sulfate and reprecipitated
with the anti-ubiquitin FK2 mAb, or an equivalent quantity of W6/
32 mAb (anti-HLA class I, does not bind H-2Db) as a negative control.
The primary precipitation products were exposed for 2 days and
the secondary for 3 weeks.
(C) H-2Db-ARG has the three cytoplasmic lysines of H-2Db mutated
to arginines. Flow cytometric analysis of cell surface H-2Db showed
a marked attenuation of MK3-mediated H-2Db-ARG downregulation
compared with H-2Db-L-myc.
(D) After a 15 min pulse [P] labeling and 45 min chase [C] of L929
cells expressing flag-MK3 or flag-MK3-MUT, and H-2Db-L-myc or
H-2Db-ARG, H-2Db was immunoprecipitated with 28.14.8 mAb.
H-2Db-L-myc runs at a slightly higher molecular weight because of
the myc tag.
(E) L929 cells expressing flag-MK3 and either H-2Db-L-myc or H-2Db-
ARG were metabolically labeled in the presence of 100 M MG-
132. MK3 was immunoprecipitated with anti-flag mAb (arrow), and
associated H-2Db was recovered by reprecipitation with 28.14.8.
(F) Cells were treated as in (E). H-2Db was immunoprecipitated with
28.14.8 mAb. The complexes were dissociated by heating at 60	C
for 15 min in 1% sodium dodecyl sulfate buffer, and the supernatant
was reprecipitated with the FK2 anti-ubiquitin mAb, or an equivalent
quantity of anti-human CD8 mAb (Serotec, Oxford, UK) as a control.
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L-myc) was amplified by PCR from C57BL/6J (H-2b) mouse lymphnation and oligoubiquitination of H-2Db by MK3 sug-
node cDNA with a 3
 primer encoding the tag sequence and clonedgested that it shares a common mechanism of action
into pMSCV-IRES-PURO, derived from pMSCV-IRES-GFP by re-with KK3 and KK5. Monoubiquitination is a well charac-
placing the green fluorescent protein gene with that of puromycin
terized internalization signal for membrane glycopro- acetyl transferase plus an extra N-terminal glycine. Two truncated
teins (Hicke, 1997) and could explain how KK3 and KK5, forms of H-2Db were made in a similar way: H-2Db-VS-myc termi-
nates in a myc epitope tag after the methionine 306 residue of thewhile expressed predominantly in the ER (Coscoy and
mature protein and replaces the entire cytoplasmic tail of H-2DbGanem, 2000; Haque et al., 2000), affect glycoproteins
with a myc epitope tag; H-2Db-S-myc terminates in a myc epitopeat the cell surface. All three proteins have PHD/LAP
tag after the threonine 312 residue and thus encodes an additionalfingers and a similar arrangement of putative transmem-
KRRRNT of the H-2Db cytoplasmic tail not present in H-2Db-VS-
brane regions. Furthermore, a hybrid K3 comprising the myc. H-2Db, with its three cytoplasmic lysines mutated to arginines
PHD/LAP finger of KK3 linked to the C-terminal region (H-2Db-ARG), was generated by overlap PCR and cloned into
pMSCV-IRES-ZEO. In this vector, an NcoISalI fragment of pVgRXRof MK3 at a shared tyrosine (residue 55 of MK3) is equiv-
(Invitrogen, Carlsbad, CA) containing the Zeocin resistance genealent to native MK3 in downregulating MHC class I in
replaces the NcoISalI GFP coding fragment of pMSCV-IRES-GFP.murine cells (P.G.S., unpublished data). Thus, the PHD/
All constructs were checked by DNA sequencing. Retroviruses en-LAP motif of KK3 probably plays a similar role to that
coding each of the H-2Db derivatives were generated by transient
of MK3 in substrate ubiquitination. transfection of Phoenix-ecotropic cells and used to transduce L929
The RING fingers of E3 ubiquitin-protein ligases (Lor- cells that had previously been transduced with either pMSCV-flag-
MK3-NEO or pMSCV-flag-MK3-MUT-NEO.ick et al., 1999; Joazeiro et al., 1999) interact directly
RMA cells and the TAP-deficient RMA/S subclone (Townsendwith E2 ubiquitin conjugating enzymes (Zheng et al.,
et al., 1990) were cultured in RPMI supplemented with 100 g/ml2000), from which ubiquitin is transferred to the target
streptomycin, 100 IU/ml penicillin, 2 mM glutamine, and 10% fetalprotein. The RING-H2 zinc finger component (Hrt1) of
calf serum (PAA Laboratories, Linz, Austria). L929 cells were cultured
the cullin complex E3 ubiquitin-protein ligase, SCFCdc4, in Dulbecco’s modified Eagle’s medium, supplemented as for RPMI.
also associates with its E2 ubiquitin-conjugating en- Cells transduced with pMSCV-IRES-NEO derivatives were selected
with 2 mg/ml G418 (Life Technologies, Paisley, UK); those trans-zyme component (Cdc34) in a RING-dependent manner
duced with pMSCV-IRES-PURO derivatives were selected with 30(Deshaies, 1999; Chen et al., 2000). Thus, the mono- or
g/ml puromycin (Sigma); and those transduced with pMSCV-H-oligoubiquitination observed with MK3 may reflect the
2Db-ARG-ZEO were selected with 800 g/ml Zeocin (Invitrogen).action of specific ubiquitination components recruited
by PHD/LAP fingers. The murine homologs of yeast
Metabolic Labeling and Immune PrecipitationUbc6 and Ubc7, which mediate RING finger-dependent
Cells were washed in cysteine/methionine-deficient RPMI (ICN, Ba-ubiquitination, have recently been implicated in the deg-
singstoke, UK), supplemented with 2 mM glutamine, 5% dialyzedradation of ER membrane proteins (Tiwari and Weiss-
fetal calf serum, and 20 mM HEPES, and incubated in the same
man, 2001). However, using GST fusions of murine Ubc6 medium for 30 min at 37	C. Proteasome inhibitors, either lactacystin
and Ubc7 (kindly provided by S. Tiwari and A. Weiss- or MG-132 (Calbiochem, La Jolla, CA), were added where indicated.
The cells were then labeled with 35S-cysteine/35S-methionine (500man), we found no evidence for an association with flag-
Ci/ml; PerkinElmer Life Sciences, Cambridge, UK) for 15 to 120MK3. We also found no evidence for MK3 associating
min at 37	C and harvested either immediately or after a 30–90 minwith E2-25K or for ubiquitin carriage by flag-MK3 itself.
chase with excess (2 mM) unlabeled cysteine/methionine. HarvestedThus, the precise pathway of MK3-mediated ubiquitina-
cells were pelleted, resuspended in lysis buffer (1% Triton X-100,
tion remains speculative. This study establishes MHC 150 mM NaCl, 50 mM Tris·Cl [pH 7.4], complete ethylenediaminetet-
class I ubiquitination as a CD8 T cell evasion mecha- raacetic acid-free protease inhibitor cocktail (Roche, Lewes, UK),
2 mM phenylmethylsulfonyl fluoride, and either 5 mM iodoacetamidenism of 2-herpesviruses and identifies a role for the
or 10 mM N-ethylmaleimide), and incubated for 30 min on ice. ToPHD/LAP-type zinc binding finger in ubiquitin transfer.
identify proteins associated with MK3, 1% digitonin was used in
the lysis buffer rather than 1% Triton X-100. Nuclei and debris were
pelleted (13,000g for 5 min), and the supernatants were preclearedExperimental Procedures
at 4	C, first for 2–16 hr with formalin-fixed S. aureus (Sigma), pre-
loaded with normal rabbit serum and rabbit anti-actin serum (Sigma),Plasmids and Cell Lines
The MK3 ORF (genomic coordinates 25335–24730) was amplified and then for 1–16 hr with protein A-Sepharose or protein G-agarose
(Sigma). Primary antibody was added to the precleared lysates forby polymerase chain reaction (PCR) from MHV-68 genomic DNA.
EcoRI and XhoI restriction sites were included in the 5
 and 3
 1–16 hr at 4	C, followed by a further 1 hr with protein A-Sepharose
or protein G-agarose. To immunoprecipitate H-2Db, we used 28.14.8primers, respectively. The 5
 primer also encoded an ACCACC trans-
lation initiation consensus and an N-terminal flag epitope tag (HB-27; American Type Culture Collection, Rockville, MD) or B22.249
mAb (provided by Dr. T. Elliott, University of Southampton, UK). The(DYKDDDDK). The PCR product was cloned into pMSCV-IRES-NEO
(Stevenson et al., 2000). Replication-defective retrovirus, generated 28.14.8 mAb recognizes the 3 domain of H-2Db (Townsend et al.,
1990) and depends on correct folding and intact disulphide cross-by transient transfection of Phoenix-amphotropic cells with pMSCV-
flag-MK3-NEO, was used to transduce RMA cells in the presence linking of this domain but is independent of peptide and 2M binding.
The B22.249 mAb recognizes only fully assembled H-2Db complexesof 6 g/ml polybrene (Sigma, St. Louis, MO) (RMA-flag-MK3). RMA-
MK3-flag cells were made in the same way as RMA-flag-MK3 cells, (Townsend et al., 1990). Anti-c-myc (clone 9E10; Sigma) was used
to precipitate myc-tagged H-2Db heavy chain independent of con-except that the flag sequence was included in the 3
 primer so as
to be at the MK3 C terminus. MK3 with a 5
 truncation was generated formation. Ubiquitinated proteins were precipitated with the anti-
ubiquitin mAb FK2 (Affiniti). Flag-tagged MK3 was precipitated di-using an upstream primer that started translation with a flag epitope
at the residue 36 leucine (Figure 1A) (RMA-flag-MK3-DEL). MK3 rectly with anti-flag M2-agarose (Sigma). In each case, the beads
with bound immune complexes were washed three times in lysislacking the C-terminal 39 residues was generated using a down-
stream primer that provided a stop codon after the alanine 162 buffer to remove unbound protein. Where indicated, bound glyco-
proteins were digested with endoglycosidase H (endo H) or endo Fresidue (RMA-flag-MK3-CT). MK3 with the two C-terminal cysteine
residues of the PHD/LAP motif converted to glycines was generated (New England Biolabs, Beverly, MA) according to the manufacturer’s
instructions. All samples were boiled in Laemmli buffer and analyzedby overlap PCR (RMA-flag-MK3-MUT).
H-2Db with a C-terminal myc epitope tag (EQKLISEEDL) (H-2Db- by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
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Flow Cytometry Progressive loss of CD8 T cell-mediated control of a -herpesvirus
in the absence of CD4 T cells. J. Exp. Med. 184, 863–871.Cells were washed in PBS/azide (0.01%)/BSA (0.1%), incubated for
10 min with 10% goat serum, and stained on ice for 1 hr with 28.14.8 Chen, A., Wu, K., Fuchs, S.Y., Tan, P., Gomez, C., and Pan, Z.Q.
mAb. They were then washed, stained with goat anti-mouse IgG- (2000). The conserved RING-H2 finger of ROC1 is required for ubiqui-
FITC (Dako, Carpinteria, CA) for 1 hr, washed again, and analyzed tin ligation. J. Biol. Chem. 275, 15432–15439.
using a FACSort and Lysys II (BD PharMingen, San Diego, CA).
Coscoy, L., and Ganem, D. (2000). Kaposi’s sarcoma-associated
Graphs were plotted using FCSPress 1.2 (www.fcspress.com). To
herpesvirus encodes two proteins that block cell surface display of
selectively permeabilize the cytoplasmic membrane, RMA cells were
MHC class I chains by enhancing their endocytosis. Proc. Natl.
washed in serum-free medium, incubated for 5 min on ice with
Acad. Sci. USA 97, 8051–8056.
400 U/ml streptolysin-O (provided by Dr. P. J. Lehner, University of
Deshaies, R.J. (1999). SCF and Cullin/Ring H2-based ubiquitin li-Cambridge, UK), incubated at 37	C for 5 min, and washed once in
gases. Annu. Rev. Cell Dev. Biol. 15, 435–467.PBS. The cells were then fixed in 2% paraformaldehyde for 20 min
de Virgilio, M., Weninger, H., and Ivessa, N.E. (1998). Ubiquitinationat room temperature. For complete permeabilization, cells were in-
is required for the retro-translocation of a short-lived luminal endo-cubated after fixation in PBS with 1% Triton for 10 min at room
plasmic reticulum glycoprotein to the cytosol for degradation by thetemperature. All cells were washed in PBS/BSA and blocked with
proteasome. J. Biol. Chem. 273, 9734–9743.1% fish skin gelatin and 10% goat serum for 15 min, followed by
staining with anti-flag-M2 mAb (Sigma) and goat anti-mouse IgG- Ehtisham, S., Sunil-Chandra, N.P., and Nash, A.A. (1993). Pathogen-
FITC or rabbit anti-calreticulin (Stressgen, Victoria, British Columbia, esis of murine gammaherpesvirus infection in mice deficient in CD4
Canada) and swine anti-rabbit IgG-FITC (Dako). and CD8 T cells. J. Virol. 67, 5147–5252.
Everett, R.D. (1999). A surprising role for the proteasome in the
Immunofluorescence regulation of herpesvirus infection. Trends Biochem. Sci. 24,
MEF-1 cells (Stevenson, et al., 1998) were adhered overnight onto 293–295.
coverslips and transfected with flag-MK3 in pcDNA3 (Invitrogen)
Friedlander, R., Jarosch, E., Urban, J., Volkwein, C., and Sommer, T.
using Fugene-6 (Roche). After 28 hr, the cells were fixed in acetone/
(2000). A regulatory link between ER-associated protein degradation
methanol or 2% paraformaldehyde, permeabilized with 1% Triton
and the unfolded-protein response. Nat. Cell Biol. 2, 379–384.
X-100, and stained with rat anti-LAMP-1 mAb (BD PharMingen) plus
Haque, M., Chen, J., Ueda, K., Mori, Y., Nakano, K., Hirata, Y.,goat anti-rat IgG-Alexa 594 (Molecular Probes, Eugene, OR); rabbit
Kanamori, S., Uchiyama, Y., Inagi, R., Okuno, T., et al. (2000). Identifi-anti-calreticulin (Stressgen) plus goat anti-rabbit IgG-Alexa 594 (Mo-
cation and analysis of the K5 gene of Kaposi’s sarcoma-associatedlecular Probes); or rabbit anti-calnexin (Stressgen) plus goat anti-
herpesvirus. J. Virol. 74, 2867–2875.rabbit IgG-Alexa 594. In each case, this was followed by staining
with biotinylated anti-flag M2 (Sigma) plus streptavidin-Alexa 488 Hicke, L. (1997). Ubiquitin-dependent internalization and down-reg-
(Molecular Probes). Images were obtained on a Leica Confocal mi- ulation of plasma membrane proteins. FASEB J. 11, 1215–1226.
croscope using Microsoft TCSNT software. Hughes, E.A., Hammond, C., and Cresswell, P. (1997). Misfolded
major histocompatibility complex class I heavy chains are translo-
Acknowledgments cated into the cytoplasm and degraded by the proteasome. Proc.
Natl. Acad. Sci. USA 94, 1896–1901.
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